Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Blood (2024) 144 (Supplement 1): 6874.

https://doi.org/10.1182/blood-2024-201755

Published: 2024

Journal Articles

Minimal Residual Disease Testing in Relapsed Systemic AL Amyloidosis

Xia Wu, Denis Toskic, Teresa Fogaren, Nancy Coady Lyons, Vasil Mico, Ping Zhou, Stephanie Scalia, Xun Ma, Raymond Comenzo

Blood (2024) 144 (Supplement 1): 3302.

https://doi.org/10.1182/blood-2024-200434

Published: 2024

Journal Articles

Bone Marrow Interstitial Light-Chain Amyloid and Its Microenvironment

Ping Zhou, Tanya Karagiannis, Albert Tai, Xun Ma, Denis Toskic, Teresa Fogaren, Nancy Coady Lyons, Monika Pilichowska, Xia Wu, Stephanie Scalia, Raymond Comenzo

Blood (2023) 142 (Supplement 1): 3317.

https://doi.org/10.1182/blood-2023-178029

Published: 2023

Journal Articles

Teclistamab Induces Rapid Responses in Patients with Relapsed/Refractory AL Amyloidosis

Hashim Mann, Denis Toskic, Karen Pak, Patrick Willard, Teresa Fogaren, Raymond Comenzo

Blood (2023) 142 (Supplement 1): 6766.

https://doi.org/10.1182/blood-2023-182971

Published: 2023

Journal Articles

The Clusterin/Von Willebrand Factor Ratio Is Significantly Lower in Marrow Plasma from AL λ-Type Than from λ-Isotype Monoclonal Gammopathy Patients

Stephanie Scalia, Denis Toskic, Ping Zhou, Mahesh M Mansukhani, Lisa Lee, Sandy W. Wong, Sascha A. Tuchman, James E. Hoffman, Teresa Fogaren, Cindy Varga, Suzanne Lentzsch, Raymond Comenzo

Blood (2022) 140 (Supplement 1): 10120–10121.

https://doi.org/10.1182/blood-2022-162352

Published: 2022

Journal Articles

Next Generation Sequencing Identifies Light-Chain Amyloid (AL)-Related Igvl Genes in Patients with λ Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Ping Zhou, Mahesh M Mansukhani, Denis Toskic, Stephanie Scalia, Lisa Lee, Sandy W. Wong, Sascha A. Tuchman, James E. Hoffman, Teresa Fogaren, Cindy Varga, Suzanne Lentzsch, Raymond Comenzo

Blood (2022) 140 (Supplement 1): 10048–10049.

https://doi.org/10.1182/blood-2022-157790

Published: 2022

Journal Articles

Belantamab Mafadotin in Patients with Relapsed/Refractory AL Amyloidosis with Myeloma

Yifei Zhang, Amandeep Godara, Stacey Pan, Denis Toskic, Teresa Fogaren, Douglas W. Sborov, Raymond Comenzo, Ankit Kansagra

Blood (2021) 138 (Supplement 1): 1670.

https://doi.org/10.1182/blood-2021-151365

Published: 2021

Journal Articles

Therapeutic Activity of Combining BCL-2 and HMG-CoA Reductase Inhibition in Systemic Light-Chain Amyloidosis

Ping Zhou, MDPhD, Hashim Mann, MD, Xun Ma, DMD, MSc, PhD, Teresa Fogaren, NP, Yifei Zhang, MD, Denis Toskic, BS, Chakra P Chaulagain, MD, Cindy Varga, MDBSc, Raymond L. Comenzo, MD, Amandeep Godara, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-142656

Published: 2020

Journal Articles

B-Cell Maturation Antigen (BCMA) in Systemic Light-Chain Amyloidosis (AL): Association with Disease Activity and Its Modulation with Gamma-Secretase Inhibition

Amandeep Godara, MD, Ping Zhou, MD PhD, Benjamin Rosenthal, BS, Adin Kugelmass, BSc, Denis Toskic, BS, Teresa Fogaren, NP, Cindy Varga, MD BSc, Raymond L Comenzo, MD

Blood (2019) 134 (Supplement_1): 4409.

https://doi.org/10.1182/blood-2019-126988

Published: 2019

Journal Articles

In Systemic Light-Chain Amyloidosis Complete and Very Good Partial Responses Are Not Enough: Involved Free Light Chain (iFLC) Levels < 10mg/L Are Associated with Optimal Long-Term Survival

Amandeep Godara, MD, Denis Toskic, BS, Benjamin Rosenthal, BS, Cindy Varga, MD BSc, Adin Kugelmass, BSc, Ping Zhou, MD PhD, Teresa Fogaren, NP, Raymond L Comenzo, MD

Blood (2019) 134 (Supplement_1): 4369.

https://doi.org/10.1182/blood-2019-127004

Published: 2019

Journal Articles

Senescent CD8+ T Cells in Myeloma Patients: Implications for Cellular Therapies

Lisa Xingguang Lee, MD, Denis Toskic, Xun Ma, DMD, MSc, PhD, Ping Zhou, MD PhD, Adin Kugelmass, BSc, Teresa Fogaren, NP, Raymond L Comenzo, MD

Blood (2018) 132 (Supplement 1): 5688.

https://doi.org/10.1182/blood-2018-99-118514

Published: 2018

Journal Articles

Identifying a Murine Xenograft Model Relevant to Light-Chain Specific Approaches to Human Ig Light-Chain Diseases

Adin Kugelmass, BSc, Ping Zhou, MD PhD, Xun Ma, DMD, MSc, PhD, Denis Toskic, Amandeep Godara, MD, Melissa Warner, BS, Lisa Xingguang Lee, MD, Teresa Fogaren, NP, Cindy Varga, MD BSc, Raymond L Comenzo, MD

Blood (2018) 132 (Supplement 1): 5611.

https://doi.org/10.1182/blood-2018-99-119381

Published: 2018

Journal Articles

Effective Lipidoid Nanoparticle Delivery In Vivo of siRNA Targeting Kappa Light Chain Production in a Murine Xenograft Model

Xun Ma, DMD, MSc, PhD, Ping Zhou, MD PhD, Adin Kugelmass, BSc, Denis Toskic, Melissa Warner, BS, Lisa X. Lee, MD, Teresa Fogaren, NP, Ming Wang, PhD, Yamin Li, Liu Yang, Qiaobing Xu, Raymond Comenzo

Blood (2018) 132 (Supplement 1): 3208.

https://doi.org/10.1182/blood-2018-99-112682

Published: 2018

Journal Articles

Seeking AL Amyloidosis Very Early: The SAVE Trial — Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma

Ping Zhou, MD PhD, Adin Kugelmass, BSc, Denis Toskic, Melissa Warner, BS, Lisa X. Lee, MD, Teresa Fogaren, NP, Cindy Varga, MD BSc, Raymond L Comenzo, MD

Blood (2018) 132 (Supplement 1): 1903.

https://doi.org/10.1182/blood-2018-99-112902

Published: 2018

Journal Articles

Daratumumab Activity Is Agnostic to Fc Gamma Receptor 3A (FcγR3A) 158 Genotype in Patients with Primary Refractory or Relapsed Systemic AL Amyloidosis

Lisa Xingguang Lee, MD, Katelynn Ho, Ping Zhou, PhD MD, Cindy Varga, MD BSc, Teresa Fogaren, NP, Denis Toskic, Adin Kugelmass, Raymond Comenzo, MD

Blood (2017) 130 (Supplement 1): 3164.

https://doi.org/10.1182/blood.V130.Suppl_1.3164.3164

Published: 2017

NARROW

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Minimal Residual Disease Testing in Relapsed Systemic AL Amyloidosis

Bone Marrow Interstitial Light-Chain Amyloid and Its Microenvironment

Teclistamab Induces Rapid Responses in Patients with Relapsed/Refractory AL Amyloidosis

The Clusterin/Von Willebrand Factor Ratio Is Significantly Lower in Marrow Plasma from AL λ-Type Than from λ-Isotype Monoclonal Gammopathy Patients

Next Generation Sequencing Identifies Light-Chain Amyloid (AL)-Related Igvl Genes in Patients with λ Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Belantamab Mafadotin in Patients with Relapsed/Refractory AL Amyloidosis with Myeloma

Therapeutic Activity of Combining BCL-2 and HMG-CoA Reductase Inhibition in Systemic Light-Chain Amyloidosis

B-Cell Maturation Antigen (BCMA) in Systemic Light-Chain Amyloidosis (AL): Association with Disease Activity and Its Modulation with Gamma-Secretase Inhibition

In Systemic Light-Chain Amyloidosis Complete and Very Good Partial Responses Are Not Enough: Involved Free Light Chain (iFLC) Levels < 10mg/L Are Associated with Optimal Long-Term Survival

Senescent CD8+ T Cells in Myeloma Patients: Implications for Cellular Therapies

Identifying a Murine Xenograft Model Relevant to Light-Chain Specific Approaches to Human Ig Light-Chain Diseases

Effective Lipidoid Nanoparticle Delivery In Vivo of siRNA Targeting Kappa Light Chain Production in a Murine Xenograft Model

Seeking AL Amyloidosis Very Early: The SAVE Trial — Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma

Daratumumab Activity Is Agnostic to Fc Gamma Receptor 3A (FcγR3A) 158 Genotype in Patients with Primary Refractory or Relapsed Systemic AL Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only